Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Not a forecast

Rules 1.1.0 · as of 14 Sep 2026

Rick Doblin · Said 18 Aug 2018 · doblin-0078

Quote

Not a forecast

“When MAPS can proceed into actual Phase 3 clinical trials for EMA approval depends on how quickly we can raise $8.5 million—ideally by the end of 2018.”
· From the Desk of Rick Doblin, Ph.D. – Summer 2018 (MAPS Bulletin Vol. 28, No. 2) · own post

European Phase 3 funding target after the EMA Scientific Advice process.

Descriptive, retrospective, or a statement of preference; no future state asserted.

← Earlier · Later → · All statements